This case suggests a potential Valsatran Pemphigoid side effect(s) that can have serious consequences. A 78-year-old female patient from GREECE (weight:NA) was diagnosed with the following health condition(s): NA and used Valsatran (dosage: NA) starting NS. Soon after starting Valsatran the patient began experiencing various side effects, including:
Drugs used concurrently:Metformin Hydrochloride (2000 Mg; Po)
Vildagliptin (no Pref. Name) (100 Mg; Po)
Although Valsatran demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pemphigoid, may still occur.